Last reviewed · How we verify
pancreatic enzyme supplement
At a glance
| Generic name | pancreatic enzyme supplement |
|---|---|
| Also known as | Creon |
| Sponsor | University of Pittsburgh |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Management of Steatorrhea in Children and Young Adults With Alagille Syndrome After Liver Transplantation (PHASE2)
- Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO) (NA)
- Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial) (NA)
- CREON for the Treatment of Post-RYGB Hypoglycemia (PHASE1)
- Assessment of a PERT-free Nutritional Therapeutic Delivery System for Cystic Fibrosis (NA)
- Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic Fibrosis (NA)
- Irritable Bowel Syndrome Evaluation and Treatment in Primary Care (PHASE4)
- The Effects of High Dose Pancreatic Enzyme Replacement Therapy After Pancreatoduodenectomy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pancreatic enzyme supplement CI brief — competitive landscape report
- pancreatic enzyme supplement updates RSS · CI watch RSS
- University of Pittsburgh portfolio CI